Upper urinary tract urothelial carcinoma: What have we learned in the last 4 years?

Therapeutic Advances in Urology

Volumn 3, Issue 2, 2011, Pages 69-80

  Remzi, Mesut ^a   Shariat, Shahrokh ^b   Huebner, Wilhelm ^a   Fajkovic, Harun ^b   Seitz, Christian ^c  

^a Landeskrankenhaus Weinviertel Korneuburg ^*  (Austria)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c St John of God Hospital   (Austria)

Author keywords

endoscopic; laparoscopic; nephroureterectomy; renal pelvis; upper tract urothelial carcinoma; ureter

Indexed keywords

CISPLATIN;

CANCER DIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HYDRONEPHROSIS; INFORMATION RETRIEVAL; KIDNEY FUNCTION; LYMPHADENECTOMY; MEDLINE; NEPHROURETERECTOMY; NOMOGRAM; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CARCINOMA;

EID: 79959227484     PISSN: 17562872     EISSN: 17562880     Source Type: Journal    
DOI: 10.1177/1756287211403349     Document Type: Review

References (99)

1. Abe T. Shinohara N. Muranaka M. Sazawa A. Maruyama S. Osawa T. (2010) Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re evaluation of negative lymph nodes. Eur J Surg Oncol 36: 1085–1091.
2. Abouassaly R. Alibhai S.M. Shah N. Timilshina N. Fleshner N. Finelli A. (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 74: 895–901.
3. Agarwal D.K. Khaira H.S. Clarke D. Raymond T. (2008) Modified transurethral technique for the management of distal ureter during laparoscopic assisted nephroureterectomy. Urology 71: 740–743.
4. Akkad T. Brunner A. Pallwein L. Gozzi C. Bartsch G. Mikuz G. (2007) Fluorescence in situ hybridization for detecting upper urinary tract tumors–a preliminary report. Urology 70: 753–757.
5. Berger A. Haber G.P. Kamoni K. Aron M. Desai M.M. Kaouk J.H. Gill I.S. (2008) Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. J Urol 180: 849–854.
6. Bolenz C. Fernandez M.I. Trojan L. Herrmann E. Becker A. Weiss C. (2008) Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology 72: 364–369.
7. Bolenz C. Shariat S.F. Fernandez M.I. Margulis V. Lotan Y. Karakiewicz P.I. (2009) Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density. BJU Int 103: 302–306.
8. Brien J.C. Shariat S.F. Herman M.P. Ng C.K. Scherr D.S. Scoll B. (2010) Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184: 69–73.
9. Busby J.E. Brown G.A. Matin S.F. (2008) Comparing lymphadenectomy during radical nephroureterectomy: open versus laparoscopic. Urology 71: 413–416.
10. Capitanio U. Shariat S.F. Isbarn H. Weizer A. Remzi M. Roscigno M. (2009) Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56: 1–9.
11. Cauberg E.C.C. Salomons M.A. Kümmerlin I.P.E.D. de Reijke T.M. Zwinderman A.H. de la Rosette J.J.M.C.H. (2009) Trends in epidemiology and treatment of upper urinary tract tumours in the Netherlands 1995–2005: an analysis of PALGA, the Dutch national histopathology registry. BJU Int 105: 922–927.
12. Chen A.A. Grasso M. (2008) Is there a role for FISH in the management and surveillance of patients with upper tract transitional-cell carcinoma? J Endourol 22: 1371–1374.
13. Childs M.A. Wood C.G. Spiess P.E. Debiane L.G. Hernandez M. Matin S.F. (2010) Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Can J Urol 17: 5184–5189.
14. Cho H.J. Kim S.J. Yoon B.L. Lee J.Y. Kim S.W. Hwang T. (2010) A novel bulldog clamp technique for management of a distal ureter and bladder cuff during laparoscopic nephroureterectomy. J Endourology 24: 1719–1720.
15. Chung S.D. Chen S.C. Wang S.M. Chueh S.C. Lai M.K. Huang C.Y. (2009) Long-term outcome of hand-assisted laparoscopic nephroureterectomy for pathologic T3 upper urinary tract urothelial carcinoma. J Endourol 23: 75–80.
16. Chung S.D. Wang S.M. Lai M.K. Huang C.Y. Liao C.H. Huang K.H. (2008) Lymphovascular invasion predicts poor outcome of urothelial carcinoma of renal pelvis after nephroureterectomy. BJU Int 103: 1047–1051.
17. Cornu J.N. Roupret M. Carpentier X. Geavlete B. Gil Diez de Medina S. Cussenot O. Traxer O. (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28: 151–156.
18. Divrik R.T. Sahin A. Altok M. Unlü N. Zorlu F. (2007) The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer. J Urol 178: 802–806.
19. Dragicevic D. Djokic M. Pekmezovic T. Vuksanovic A. Micic S. Hadzi-Djokic J. (2009) Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma. Urol Int 82: 335–340.
20. Eandi J.A. Nelson R.A. Wilson T.G. Josephson D.Y. (2010) Oncologic outcomes for complete robot-assisted laparoscopic management of upper-tract transitional cell carcinoma. J Endourol 24: 969–975.
21. Favaretto R.L. Shariat S.F. Chade D.C. Godoy G. Kaag M. Cronin A.M. (2010) Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol 58: 645–651.
22. Fernandez M.I. Shariat S.F. Margulis V. Bolenz C. Montorsi F. Suardi N. (2009) Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study. Urology 73: 142–146.
23. Fritsche H.M. Novara G. Burger M. Gupta A. Matsumoto K. Kassouf W. (2011) Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol Semin Original Invest 2011; DOI: 10.1016/j.urolonc.2010.07.010.
24. Fromont G. Rouprêt M. Amira N. Sibony M. Vallancien G. Validire P. (2005) Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. Eur Urol 48: 764–770.
25. Gadzinski A.J. Roberts W.W. Faerbert G. Wolf J.S. Jr (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183: 2148–2153.
26. Ghazi A. Shefler A. Gruell M. Zimmermann R. Janetschek G. (2010) A novel approach for a complete laparoscopic nephroureterectomy with bladder cuff excision. J Endourol 24: 415–419.
27. Go A.S. Chertow G.M. Fan D. McCulloch C.E. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Eng J Med 351: 1296–1305.
28. Greco F. Wagner S. Hoda R.M. Hamza A. Fornara P. (2009) Laparoscopic vs open radical nephroureterectomy for upper urinary tract urothelial cancer: oncological outcomes and 5-year follow-up. BJU Int 104: 1274–1278.
29. Guzzo T.J. Schaeffer E.M. Allaf M.E. (2008) Laparoscopic radical nephroureterectomy with en-bloc distal ureteral and bladder cuff excision using a single position pneumovesicum method. Urology 72: 850–852.
30. Hellenthal N.J. Shariat S.F. Margulis V. Karakiewicz P.I. Roscigno M. Remzi M. (2009) Adjuvant chemotherapy for high-risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration. J Urol 182: 900–906.
31. Hemal A.K. Kumar A. Gupta N.P. Seth A. (2008) Retroperitoneal nephroureterectomy with excision of cuff of the bladder for upper urinary tract transitional cell carcinoma: comparison of laparoscopic and open surgery with long-term follow-up. World J Urol 26: 381–386.
32. Herman M.P. Svatek R.S. Lotan Y. Karakiewizc P.I. Shariat S.F. (2008) Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva Urol Nefrol 60: 217–235.
33. Herr H.W. (2009) Is metastasectomy for urothelial carcinoma worthwhile? Eur Urol 55: 1300–1301.
34. Hora M. Eret V. Urge T. Klecka J. Kococska P. Petr S. (2009) Antegrade mini-invasive nephroureterectomy: laparoscopic nephrectomy, transurethral excision of ureterovesical junction and lower abdominal incision. Urol Int 83: 264–270.
35. Hu J.C. Silletti J.P. Willams S.B. (2008) Initial experience with robot-assisted minimally invasive nephroureterectomy. J Endourol 22: 699–704.
36. Huang W.C. Levey A.S. Serio A.M. Snyder M. Vickers A.J. Raj G.V. (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7: 735–740.
37. Huang W.W. Huang H.Y. Liao A.C. Shiue Y.L. Tai H.L. Lin C.M. (2009) Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Pathol Int 59: 642–649.
38. Irwin B.H. Berger A.K. Brandina R. Stein R. Desai M.M. (2010) Complex percutaneous resections for upper-tract urothelial carcinoma. J Endourol 24: 367–370.
39. Isbarn H. Jeldres C. Shariat S.F. Liberman D. Sun M. Lughezzani G. (2009) Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 182: 2177–2181.
40. Ishikawa S. Abe T. Shinohara N. Harabayashi T. Sazawa A. Maruyama S. (2010) Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract. J Urol 184: 883–887.
41. Jeldres C. Lughezzani G. Sun M. Isbarn H. Shariat S. Budäus L. (2010) Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol 183: 1324–1329.
42. Johannes J.R. Nelson E. Bibbo M. Bagley D.H. (2010) Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance. J Urol 184: 879–882.
43. Kaag M.G. O–Malley R.L. O–Malley P. Godoy G. Chen M. Smaldone M.C. (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58: 581–587.
44. Kamihira O. Hattori R. Yamaguchi A. Kawa G. Ogawa O. Habuchi T. (2009) Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol 55: 1397–1409.
45. Kikuchi E. Margulis V. Karakiewicz P. Roscigno M. Mikami S. Lotan Y. (2009) Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. JCO 27: 612–618.
46. Kim D.S. Lee Y.H. Cho K.S. Cho N.H. Chung B.H. Hong S.J. (2010) Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma. Urology 75: 328–332.
47. Kondo T. Hashimoto Y. Kobayashi H. Iizuka J. Nakazawa H. Ito F. Tanabe K. (2010) Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival. Int J Urol 17: 848–854.
48. Koppie T.M. Shariat S.F. Nelson E.C. Margulis V. Remzi M. Montorsi F. (2008) Adjuvant chemotherapy for upper tract transitional cell carcinoma: results from the Upper Tract UCC Consortium. J Urol 179: 119A–119A.
49. Lane B.R. Smith A.K. Larson B.T. Gong M.C. Campbell S.C. Raghavan D. (2010) Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy. Cancer 15: 2967–2973.
50. Langner C. Hutterer G. Chromecki T. Winkelmayer I. Rehak P. Zigeuner R. (2006) pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tract. Mod Pathol 19: 272–279.
51. Lehmann J. Suttmann H. Albers P. Volkmer B. Gschwend J.E. Fechner G. (2009) Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur Urol 55: 1293–1299.
52. Leibovich B.C. Cheville J.C. Lohse C.M. Zincke H. Frank I. Kwon E.D. (2005) A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 174: 1759–1763.
53. Li C.C. Chang T.H. Wu W.J. Ke H.L. Huang S.P. Tsai P.C. (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54: 1127–1135.
54. Li W.M. Li C.C. Ke H.L. Wu W.J. Huang C.N. Huang C.H. (2009) The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy. J Urol 182: 451–458.
55. Li W.M. Shen T.J. Li C.C. Ke H.L. Wei Y.C. Wu W.J. (2010) Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol 57: 963–969.
56. Lucas S.M. Svatek R.S. Olgin G. Arriaga Y. Kabbani W. Sagalowsky A.I. Lotan Y. (2008) Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int 102: 172–176.
57. Lughezzani G. Jeldres C. Isbarn H. Shariat S.F. Sun M. Pharand D. (2010a) A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 75: 118–124.
58. Lughezzani G. Sun M. Perrotte P. Shariat S.F. Jeldres C. Budäus L. (2010b) Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results Database. Urology 75: 321–327.
59. Lughezzani G. Sun M. Perrotte P. Shariat S.F. Jeldres C. Budäus L. (2010c) Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol 57: 956–962.
60. Luo B. Li W. Deng C.H. Zheng F.F. Sun X.Z. Wang D.H. Dai Y.P. (2009a) Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma. Cancer Genet Cytogenet 189: 93–97.
61. Luo H.L. Kang C.H. Chiang P.H. (2009b) Gasless hand-assisted retroperitoneoscopic nephroureterectomy. J Endourol 23: 69–74.
62. Margulis V. Shariat S.F. Matin S.F. Kamat A.M. Zigeuner R. Kikuchi E. (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115: 1224–1233.
63. Margulis V. Youssef R.F. Karakiewicz P. Lotan Y. Wood C.G. Zigeuner R. (2010) Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184: 453–458.
64. Marin-Aguilera M. Mengual L. Ribal M.J. Musquera M. Ars E. Villavicencia H. (2007) Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol 51: 409–415.
65. Matin S.F. Margulis V. Kamat A. Wood C.G. Grossmann H.B. Brown G.A. (2010) Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma. Cancer 116: 3127–3134.
66. Mian C. Mazzoleni G. Vikoler S. Martini T. Knüchel-Clark R. Zaak D. (2010) Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours. Eur Urol 58: 288–292.
67. Mueller T.J. DaJusta D.G. Cha D.Y. Kim I.Y. Ankem M.K. (2010) Ureteral fibrin sealant injection of the distal ureter during laparoscopic nephroureterectomy–a novel and simple modification of the Pluck technique. Urology 75: 187–193.
68. Munoz J.J. Ellison L.M. (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164: 1523–1525.
69. Ng C.K. Shariat S.F. Lucas S.M. Bagrodia A. Lotan Y. Scherr D.S. Raman J.D. (2011) Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma? Urol Oncol Semin Original Invest 29: 27–32.
70. Nieder A.M. Soloway M.S. Herr H.W. (2007) Should we abandon the FISH test? Eur Urol 51: 1469–1471.
71. Novara G. De Marco V. Gottardo F. Dalpiaz O. Bouygues V. Galfano A. (2007) Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract multi-institutional dataset from 3 European centers. Cancer 110: 1715–1722.
72. Novara G. De Marco V. Dalpiaz O. Galfano A. Bouygues V. Gardiman M. (2009) Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: Multi-institutional dataset from three European centers. Int J Urol 16: 187–191.
73. Oosterlinck W. Solsona E. van der Meijden A.P. Sylvester R. Bohle A. Rintala E. (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46: 147–154.
74. Pieras E. Frontera G. Ruiz X. Vicens A. Ozonas M. Piza P. (2010) Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 106: 1319–1323.
75. Raman J.D. Ng C.K. Scherr D.S. Margulis V. Lotan Y. Bensalah K. (2010) Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 57: 1072–1079.
76. Remzi M. Haitel A. Margulis V. Karakiewicz P.I. Montorsi F. Kikuchi E. (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103: 307–311.
77. Roscigno M. Shariat S.F. Margulis V. Karakiewicz P.I. Remzi M. Kikuchi E. (2009) Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181: 2482–2489.
78. Roupret M. Zigeuner R. Palou J. Boehle A. Kaasinen E. Sylvester R. (2011) European Guidelines for the diagnosis and management of upper urinary tract transitional cell carcinoma. 2011 update. Eur Urol DOI: 10.1016/j.eururo.2010.12.042.
79. Schatteman P. Chatzopoulos C. Assenmacher C. de Visscher L. Jorion J. Blaze V. (2007) Laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: results of a Belgian retrospective multicentre survey. Eur Urol 51: 1633–1638.
80. Secin F.P. Koppie T.M. Salamanca J.I.M. Bokhari S. Raj G.V. Olgac S. (2007) Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer. Int J Urol 14: 26–32.
81. Seitz C. Gupta A. Shariat S.F. Matsumoto K. Kassouf W. Walton T.J. (2010) Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: An international validation study. J Urol 184: 1895–1900.
82. Shariat S.F. Favaretto R.L. Gupta A. Fritsche H.M. Matsumoto K. Kassouf W. (2011) Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol DOI: 10.1007/s00345-010-0594-7.
83. Shariat S.F. Godoy G. Lotan Y. Droller M. Karakiewicz P.I. Raman J.D. (2009) Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 105: 1672–1677.
84. Simone G. Papalia R. Guaglianone S. Ferriero M. Leonardo C. Forastiere E. Galluci M. (2009) Laparoscopic versus open nephroureterectomy: perioperative and oncologic outcomes from a randomised prospective study. Eur Urol 56: 520–526.
85. Simone G. Papalia R. Loreto A. Leonardo C. Sentinelli S. Gallucci M. (2008) Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma. BJU Int 103: 1052–1057.
86. Steffens J. Humke U. Alloussi S. Ziegler M. Siemer S. (2007) Partial nephrectomy and autotransplantation with pyelovesicostomy for renal urothelial carcinoma in solitary kidneys: a clinical update. BJU Int 99: 1020–1023.
87. Sundi D. Svatek R.S. Margulis V. Wood C.G. Matin S.F. Dinney C.P. Kamat A.M. (2011) Upper tract urothelial carcinoma: Impact of time to surgery. Urol Oncol, in press.
88. Tada Y. Yokomizo A. Koga H. Seki N. Kuroiwa K. Tatsugami K. (2010) Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium-YAG and/or holmium-YAG laser ablation. BJU Int 106: 362–366.
89. Tan L.B. Chang L.L. Cheng K.I. Huang C.H. Kwan A.L. (2008) Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population. BJU Int 103: 312–316.
90. Terakawa T. Miyake H. Hara I. Takenaka A. Fujisawa M. (2008) Retroperitoneoscopic nephroureterectomy for upper urinary tract cancer: a comparative study with conventional open retroperitoneal nephroureterectomy. J Endourol 22: 1693–1699.
91. Thompson R.H. Krambeck A.E. Lohse C.M. Elliot D.S. Patterson D.E. Blute M.L. (2008) Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJU Int 102: 1107–1110.
92. Waldert M. Karakiewicz P. Raman J.D. Remzi M. Isbarn H. Lotan Y. (2009) A delay in radical nephroureterectomy can lead to upstaging. BJU Int 105: 812–817.
93. Waldert M. Remzi M. Klingler H.C. Mueller L. Marberger M. (2009) The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy. BJU Int 103: 66–70.
94. Walton T.J. Novara G. Matsumoto K. Kassouf W. Fritsche H.M. Artibani W. (2011) Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int DOI: 10.1111/j.1464-410X.2010.09826.x.
95. Williams S.K. Denton K.J. Minervini A. Oxley J. Khastigir J. Timoney A.G. Keeley Jr F.X. (2008) Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma. J Endourol 22: 71–76.
96. Wu W.J. Ke H.L. Yang Y.H. Li C.C. Chou Y.H. Huang C.H. (2010) Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy? J Urol 183: 56–61.
97. Youssef R.F. Shariat S.F. Lotan Y. Wood C.G. Sagalowski A.I. Zigeuner R. (2011) Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma. Urology DOI: 10.1016/j.urology.2010.09.032.
98. Zigeuner R. Pummer K. (2008) Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors. Eur Urol 53: 720–731.
99. Zigeuner R. Shariat S.F. Margulis V. Karakiewicz P.I. Roscigno M. Weizer A. (2009) Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57: 551–551.